Article de Périodique
Prevalence and characteristics of adolescent patients with co-occurring ADHD and substance dependence (2004)
(Prévalence et caractéristiques des patients adolescents dépendants à une substance et présentant des troubles de l'attention et de l'hyperactivité concommitants)
Auteur(s) :
GORDON, S. M. ;
TULAK F. ;
TRONCALE J.
Année :
2004
Page(s) :
31-40
Langue(s) :
Anglais
Refs biblio. :
20
Domaine :
Drogues illicites / Illicit drugs
Discipline :
PSY (Psychopathologie / Psychopathology)
Thésaurus mots-clés
ADOLESCENT
;
COMORBIDITE
;
DEPENDANCE
;
TROUBLES DU COMPORTEMENT
;
TROUBLES DE L'ATTENTION
;
PREVALENCE
;
TRAITEMENT
Note générale :
Journal of Addictive Diseases, 2004, 23, (4), 31-40, tabl.
Résumé :
Estimates of co-morbidity of SUD and ADHD in addiction treatment settings range from 30% to 50%.1,2 The Schedule II psychostimulant medications, methylphenidate and dextroamphetamine, generally considered to be safe and effective in treating ADHD in adolescent patients,4 may be risky for an SUD population since individuals with SUD may have a higher likelihood of abusing or diverting the medications. 17 162 adolescent patients admitted to a residential addictions treatment program were administered a structured interview concerning ADHD and psychostimulant abuse as part of the clinical psychological evaluation administered by the staff psychologist. Results indicate 31% of patients have current ADHD diagnosis and 20% reported illicit diversion of Schedule II medication. One-third of entire adolescent patient population reported prior psychostimulant abuse. Results are discussed in terms of appropriate treatment for adolescents with co-occurring substance abuse or dependence and ADHD. (Author' s abstract)
Affiliation :
Caron Foundation, Galen Hall Road, Box 150, Wernersville, PA 19565.
Etats-Unis. United States.
Etats-Unis. United States.